Townsville, Australia

Alex Loukas

This inventor holds 4 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: James Cook University, Other. Active years: 2017-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alex Loukas. Retrieved from https://idiyas.com/inventor/alex-loukas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Smithfield, AU (2017)
  • Townsville, AU (2020 - 2024)

Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Alex Loukas: Innovator in Anti-Inflammatory Proteins

Introduction

Alex Loukas is a notable inventor based in Townsville, Australia. He has made significant contributions to the field of biochemistry, particularly in the development of modified anti-inflammatory proteins. With a total of 4 patents to his name, Loukas continues to push the boundaries of scientific innovation.

Latest Patents

One of Loukas's latest patents involves a modified Ac-TMP-2 protein. This protein is characterized by the absence of one or more acidic C-terminal amino acids typically found in a full-length or wild-type Ac-TMP-2 protein. Additionally, it may lack one or more N-terminal amino acids while retaining the amino acid sequence C-S-C at or near the N-terminus. This modified Ac-TMP-2 protein has potential applications in methods and compositions aimed at reducing or alleviating inflammation in subjects. The inflammation addressed by this invention may be associated with various diseases, including chronic gastritis, inflammatory bowel diseases such as Crohn's disease or ulcerative colitis, and respiratory diseases like asthma, emphysema, chronic bronchitis, and chronic obstructive pulmonary disease.

Career Highlights

Throughout his career, Loukas has worked with esteemed institutions, including James Cook University. His research and innovations have garnered attention in the scientific community, contributing to advancements in medical treatments and therapies.

Collaborations

Loukas has collaborated with notable colleagues such as Andrew Leech and Darren Pickering. These partnerships have further enriched his research endeavors and have led to significant advancements in his field.

Conclusion

Alex Loukas stands out as an influential inventor in the realm of anti-inflammatory proteins. His innovative work continues to pave the way for new therapeutic approaches to managing inflammation-related diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…